Generic Medicine Info
Should be taken with food. Take w/ or immediately after meals.
Severe hepatic and moderate to severe renal impairement.
Special Precautions
Patient w/ pyloric stenosis, asthma, bleeding disorders, active peptic ulcer disease. Mild to moderate hepatic and mild renal impairment or history of renal disease. Pregnancy and lactation. Monitoring Parameters Monitor renal function, LFT and CBC.
Adverse Reactions
Blood dyscrasias, aplastic anaemia, luecopenia, neutropenia, agranulocytosis, thrombocytopenia; headache, neuropathy; myocarditis, pericarditis; bronchospasm, allergic alveolitis; abdominal pain, diarrhoea, nausea, vomiting, exacerbation of ulcerative colitis, acute pancreatitis; hepatitis, cholelithiasis, increased liver enzymes; alopecia, rash, angioedema; SLE-like syndrome, arthralgia, myalgia; interstitial nephritis; fatigue; staining of the teeth.
Drug Interactions
Increased risk of blood dyscrasias w/ azathioprine and 6-mercaptopurine. Increased nephrotoxicity when used w/ NSAIDs. May decrease serum concentration of cardiac glycosides.
ATC Classification
A07EC04 - balsalazide ; Belongs to the class of aminosalicylic acid and similar antiinflammatory. Used in the treatment of intestinal inflammation.
Disclaimer: This information is independently developed by CIMS based on balsalazide from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in